Figure 2.

Varying levels of prostaglandin E-major urinary metabolite (PGE-MUM) (a) and C-reactive protein (CRP) (b) in the Cohort 2 subgroups, which reflected changes in MES scores, from the precedent colonoscopy (first CS) to the subsequent (second CS).